The National Biotechnology Safety Act authorizes the National Science Foundation to establish a research program focused on assessing the risks of biotechnology products, particularly organisms modified through genetic engineering. The bill allocates $50 million annually from 2026 through 2030 to fund research on topics like unintended genetic effects, environmental impacts, gene dispersal monitoring, and interactions between biotech organisms and wild species. Funding will go to universities, research institutions, nonprofits, and private companies, with the NSF coordinating with federal agencies like the USDA, FDA, and EPA to ensure research supports regulatory decision-making. Additionally, the bill requires the National Academies of Science, Engineering, and Medicine to conduct a two-phase study comparing the safety of biotechnology tools to conventional genetic modification methods and to make recommendations on regulatory frameworks, with results due within one and two years respectively.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.